RAFČÍKOVÁ, Julie, Marie NOVÁKOVÁ and Tibor STRAČINA. Exploring the Association between Schizophrenia and Cardiovascular Diseases: Insights into the Role of Sigma 1 Receptor. Physiological research. Praha: Fyziologický ústav AV ČR, 2023, vol. 72, Supplement 2, p. "S113"-"S126", 14 pp. ISSN 0862-8408. Available from: https://dx.doi.org/10.33549/physiolres.935099.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Exploring the Association between Schizophrenia and Cardiovascular Diseases: Insights into the Role of Sigma 1 Receptor
Authors RAFČÍKOVÁ, Julie (203 Czech Republic, belonging to the institution), Marie NOVÁKOVÁ (203 Czech Republic, belonging to the institution) and Tibor STRAČINA (703 Slovakia, belonging to the institution).
Edition Physiological research, Praha, Fyziologický ústav AV ČR, 2023, 0862-8408.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.100 in 2022
RIV identification code RIV/00216224:14110/23:00131540
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.33549/physiolres.935099
UT WoS 001049127500003
Keywords in English Schizophrenia; Cardiovascular diseases; Sigma 1 receptor
Tags 14110515, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 30/8/2023 13:38.
Abstract
Contemporary society is characterized by rapid changes. Various epidemiological, political and economic crises represent a burden to mental health of nowadays population, which may at least partially explain the increasing incidence of mental disorders, including schizophrenia. Schizophrenia is associated with premature mortality by at least 13-15 years. The leading cause of premature mortality in schizophrenia patients is high incidence of cardiovascular diseases. The specific-cause mortality risk for cardiovascular diseases in schizophrenia patients is more than twice higher as compared to the general population. Several factors are discussed as the factor of cardiovascular diseases development. Intensive efforts to identify possible link between schizophrenia and cardiovascular diseases are made. It seems that sigma 1 receptor may represent such link. By modulation of the activity of several neurotransmitter systems, including dopamine, glutamate, and GABA, sigma 1 receptor might play a role in pathophysiology of schizophrenia. Moreover, significant roles of sigma 1 receptor in cardiovascular system have been repeatedly reported. The detailed role of sigma 1 receptor in both schizophrenia and cardiovascular disorders development however remains unclear. The article presents an overview of current knowledge about the association between schizophrenia and cardiovascular diseases and proposes possible explanations with special emphasis on the role of the sigma 1 receptor.
Links
MUNI/A/1343/2022, interní kód MUName: Zátěže kardiovaskulárního systému od A po Z
Investor: Masaryk University, Loads on the cardiovascular system from A to Z
PrintDisplayed: 19/7/2024 22:23